Latest News
Tomomi Yoshida and Sarah Ohashi receive the prestigious F31 award
- December 15, 2022
With a WHRY grant, Dr. Lauren Sansing is exploring the response of brain cells to stroke in aging women.
- February 21, 2021
According to a recent study published in "Science Immunology," A team of researchers from Yale and MIT partnernered with a large clinical trial of minimally-invasive surgery to tackle defining the human neuroinflammatory response in living patients suffering from intracerebral hemorrhage.
- February 10, 2021
A scientific team at Yale led by Lauren Sansing, MD, MS, and Kevin N. Sheth, MD, is part of a three-institution research network being formed by the American Heart Association to study and treat hemorrhagic stroke.
- October 05, 2020
While continuing to focus on the impacts of COVID-19, the center has enlarged its research portfolio to include new projects on the prevention of endometrial cancer in a growing cohort of women at high risk, non-opioid pain management following a cesarean section for women with opioid use disorder who are in recovery, and sex differences in stroke.
- May 20, 2020
Women’s Health Research at Yale today announced funding for three studies investigating sex differences in stroke, endometrial cancer, and alternate pain relief for women recovering from past opioid use who are giving birth via cesarean section.
- April 17, 2020
ASCI has inducted 80 new members who come from 41 different institutions and represent excellence across the breadth of academic medicine. Four are faculty members at Yale School of Medicine.
- October 09, 2019
While patients who undergo surgery for intracerebral hemorrhage (ICH) survive at higher rates than those who do not receive surgery, they are also at high risk of significant disability, according to a new Yale-led study published in the journal JAMA.
- September 11, 2019
Yale’s Department of Neurology is one of seven medical institutions awarded $4 million from the National Institutes of Health to assess acute ischemic stroke treatments in rodent models. As a part of the Stroke Preclinical Assessment Network (SPAN), participating institutions will work together to increase the rigor surrounding testing for ischemic brain injury, taking a look at six neuroprotective therapies to improve outcomes after stroke.
- September 03, 2019Source: National Institutes of Health
Recently the National Institutes of Health called on researchers to make the standards and practices for conducting early stage, or preclinical, medical research on animals more like those used for clinical trials. To facilitate this change, NIH will fund a nationwide preclinical trial platform designed to systematically and efficiently test novel treatments for acute ischemic stroke in rodents. Seven labs will work together, as part of the Stroke Preclinical Assessment Network (SPAN), to employ rigorous, clinical research practices, like randomization and blinding, while assessing the effectiveness of six potential neuroprotective therapies in reducing ischemic brain injury. The funding estimate for the network is $4 million over three years.